Skip to main content
Clinical Trials/NCT04244162
NCT04244162
Completed
Not Applicable

Mechanisms Mediating Postoperative Neurocognitive Disorders

Massachusetts General Hospital1 site in 1 country32 target enrollmentDecember 12, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obstructive Sleep Apnea
Sponsor
Massachusetts General Hospital
Enrollment
32
Locations
1
Primary Endpoint
Postoperative cognitive dysfunction - delayed cognitive recovery
Status
Completed
Last Updated
6 months ago

Overview

Brief Summary

The purpose of this study is to examine the mechanisms of brain injury contributing to postoperative neurocognitive disorders (PNCD) in an at-risk population (obstructive sleep apnea (OSA)) undergoing surgery. The investigators will enroll 50 OSA patients scheduled for surgery. All patients will have a brain scan (fMRI) within five days before surgery and two days and six months after surgery. During this visit cognitive function will be assessed using the Wide Range Assessment of Memory and Learning (WRAML2) and Montreal Cognitive Assessment (MoCA) tests. Patients will also be asked to participate in a blood draw during the first 2 visits for fMRI (within five days of surgery and two days after surgery). The Confusion Assessment Method (CAM-S) test, will be used to examine postoperative delirium.

Detailed Description

The investigators will examine the potential mechanisms of brain injury contributing to postoperative neurocognitive disorders (PNCD) in an at-risk population (obstructive sleep apnea (OSA)). This study proposes that neuro-inflammation is associated with measurable tissue changes that can be examined with MD measures and blood biomarkers. On the day of surgery, standard of care procedures will take place. Hemodynamic vitals will be continuously monitored. As per the latest guidelines and recommendations from the American Society of Anesthesiologists (ASA), mean arterial pressure (MAP) will be targeted to \> 60 mmHg or within 20% of baseline values, and processed EEG-guided anesthesia will be monitored to maintain a patient state index between 20-50. Electronic medical records and intraoperative integrated physiologic waveform will be collected. In summary, the investigators will examine the potential mechanisms of brain injury contributing to postoperative delirium (POD) and acute and long-lasting neurocognitive deficits in an at-risk population (OSA).

Registry
clinicaltrials.gov
Start Date
December 12, 2020
End Date
August 31, 2025
Last Updated
6 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Susana Vacas, MD, PhD

Physician

Massachusetts General Hospital

Eligibility Criteria

Inclusion Criteria

  • Subjects with a diagnosis of moderate-to-severe OSA (apnea hypopnea index \[AHI\]\>15 events/hour confirmed by overnight polysomnography), scheduled for open or robotic surgery (abdominal, gynecologic, or urologic), and upper or lower extremity orthopedic procedures

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Postoperative cognitive dysfunction - delayed cognitive recovery

Time Frame: Post-surgery (within two days post surgery).

Montreal Cognitive Assessment (MoCA) test

Postoperative Delirium

Time Frame: A two times per day for up to three days or discharge from the hospital.

The Confusion Assessment Method (CAM-S) test

Preoperative cognitive function

Time Frame: pre-surgery (within five days before)

Montreal Cognitive Assessment (MoCA) test

Postoperative cognitive dysfunction - delayed cognitive recovery II

Time Frame: Post-surgery (within two days post surgery).

Wide Range Assessment of Memory and Learning (WRAML2)

Postoperative cognitive dysfunction - neurocognitive disorder II

Time Frame: Post-surgery (6 months after surgery).

Wide Range Assessment of Memory and Learning (WRAML2)

Postoperative cognitive dysfunction - neurocognitive disorder

Time Frame: Post-surgery (6 months after surgery).

Montreal Cognitive Assessment (MoCA) test

Preoperative cognitive function II

Time Frame: pre-surgery (within five days before surgery)

Wide Range Assessment of Memory and Learning (WRAML2)

Secondary Outcomes

  • Blood Serum anti-inflammatory Biomarkers(pre- (within five days before surgery))
  • Brain changes(pre- (within five days before) and post-surgery (within two days and 6 months).)
  • Blood Serum anti-inflammatory Biomarkers II(post-surgery (within two days of surgery).)
  • Brain changes II(Post-surgery (within two days post surgery).)
  • Brain changes III(Post-surgery (within six months post surgery).)

Study Sites (1)

Loading locations...

Similar Trials